<?xml version="1.0" encoding="UTF-8"?>
<ref id="B265-vaccines-08-00036">
 <label>265.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mackarehtschian</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hardin</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Boast</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Goff</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Lemischka</surname>
    <given-names>I.R.</given-names>
   </name>
  </person-group>
  <article-title>Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors</article-title>
  <source>Immunity</source>
  <year>1995</year>
  <volume>3</volume>
  <fpage>147</fpage>
  <lpage>161</lpage>
  <pub-id pub-id-type="doi">10.1016/1074-7613(95)90167-1</pub-id>
  <pub-id pub-id-type="pmid">7621074</pub-id>
 </element-citation>
</ref>
